Biotech · Private company
Triphase Research and Development III Corp.
Track this companyFree. Adds Triphase Research and Development III Corp. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- TRPH-222Phase 1 · LymphomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Study of TRPH-222 in Patients With Relapsed and/or Refractory B-Cell LymphomaPHASE1 · COMPLETED · started Oct 15, 2018ClinicalTrials.gov NCT03682796 · fetched Nov 12, 2026
- Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain CancerPHASE1 · COMPLETED · started Aug 17, 2016ClinicalTrials.gov NCT02903069 · fetched Nov 12, 2026
- Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and BevacizumabPHASE1_PHASE2 · COMPLETED · started Apr 15, 2015ClinicalTrials.gov NCT02330562 · fetched Nov 12, 2026